Radiological features of recurrent adenoid cystic carcinoma (ACC) of the head and neck following carbon ion radiotherapy
Author Block: L. Levante1, C. Fichera2, G. Fontana1, V. Dolcetti1, J. Fragomene1, B. Vischioni1, E. Orlandi1, L. Preda1, S. Imparato1; 1Pavia/IT, 2Lodi/IT
Purpose: To identify early radiological features of recurrent adenoid cystic carcinoma (ACC) of the head and neck after carbon ion radiotherapy (CIRT).
Methods or Background: Radiological features (shape, margins, mass effect, contrast enhancement, DWI, mean ADC on ROI, necrosis, side relative to treated area, location relative to initial tumor volume, growth trend, T2 and T1 signal) were retrospectively analyzed in 51 patients with recurrent ACC treated with CIRT between 2013 and 2022 at CNAO. The same variables were assessed in 51 patients without recurrence (control group). In recurrent cases, imaging was evaluated at three time points (t.p.): 6 months after treatment (t.p.0), 6 months before recurrence (t.p.1), and at recurrence (t.p.2). For controls, t.p.2 corresponded to the mean recurrence time of the other group (34 months). ΔADC values across time points were also calculated in both groups.
Results or Findings: Compared with controls, recurrent ACC exhibited significantly more frequent features (p<0.001), including rounded or lobulated shape, mass effect, homogeneous enhancement, mean ADC of 1098 mm²/s, ΔADC of –460 mm²/s, progressive growth, peripheral localization, and intermediate T2 signal. At t.p.1, these characteristics were already comparable to those observed at t.p.2, except for mean ADC, which showed a progressive reduction, and ΔADC, which had already increased compared with t.p.0 (1306 and –250 mm²/s, respectively). A reproducible radiological pattern of recurrent ACC after CIRT was identified, with some features being objectively quantifiable, particularly ΔADC, a parameter scarcely investigated to date.
Conclusion: This preliminary study outlines the main radiological features of ACC recurrence after CIRT and provides a basis for developing response criteria related to salivary gland tumors of the head and neck treated with particle therapy.
Limitations: This is a single-center study
Funding for this study: None
Has your study been approved by an ethics committee? Yes
Ethics committee - additional information: Approved by local ethical committee of Pavia (PV)